Share ownership Johnson & Johnson

JNJ

US4781601046

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 18:42:31 17/04/2026 +03			5-day change	1st Jan Change
234.65 ^USD	+0.05%		-1.38%	+13.63%

11:00am	Moberg Pharma proposes Lars Johansson as new Chairman	FW
04-16	MeiraGTx Acquires Bota-vec From Johnson & Johnson; Reports Positive Three-Year Early-Stage Data From AAV-hAQP1 Program in Xerostomia	MT

Share class: Johnson & Johnson

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	3,120,537,693	2,405,417,695 ( 77.08 %)	712,921,000 ( 22.85 %)	77.08 %

Major shareholders: Johnson & Johnson

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 9.973 %	240,349,660	9.973 %	58 751 M $
BlackRock Advisors LLC 6.474 %	156,007,213	6.474 %	38 134 M $
STATE STREET CORPORATION 5.555 %	133,869,843	5.555 %	32 723 M $
JPMorgan Investment Management, Inc. 2.43 %	58,558,238	2.43 %	14 314 M $
Geode Capital Management LLC 2.405 %	57,953,747	2.405 %	14 166 M $
BlackRock Life Ltd. 1.975 %	47,589,849	1.975 %	11 633 M $
Eaton Vance Management 1.922 %	46,325,589	1.922 %	11 324 M $
Norges Bank (13F) 1.388 %	33,459,884	1.388 %	8 179 M $
State Farm Investment Management Corp. 1.311 %	31,590,952	1.311 %	7 722 M $
Merrill Lynch International 1.176 %	28,333,601	1.176 %	6 926 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Itaú Unibanco Asset Management Ltda. 0.000477 %	172,717	0.000477 %	3 M $
Caixa DTVM SA 0.000004 %	1,340	0.000004 %	21 596 $

Breakdown by shareholder type

Institutional	57.76%
Other	7.92%
State Street Corp.	5.55%
Schweizerische Nationalbank	0.27%
Sumitomo Mitsui Trust Group, Inc.	0.25%
Manulife Financial Corp.	0.16%
Governments	0.15%
Swedbank AB	0.1%
Danske Bank A/S	0.09%
SEI Investments Co.	0.08%
The Bank of Nova Scotia	0.05%
Fifth Third Bancorp	0.05%
Skandinaviska Enskilda Banken AB	0.05%
Regions Financial Corp.	0.04%
Commerzbank AG	0.04%
Zurich Insurance Group AG	0.04%
Individuals	0.04%
Markel Group, Inc.	0.03%
First Financial Bankshares, Inc.	0.03%
Rathbones Group Plc	0.03%
Silvercrest Asset Management Group, Inc.	0.02%
Peapack-Gladstone Financial Corp.	0.02%
ING Groep NV	0.02%
Hikari Tsushin, Inc.	0.01%
First Horizon Corp. (Tennessee)	0.01%
Associated Banc-Corp	0.01%
The Allstate Corp.	0.01%
Cincinnati Financial Corp.	0.01%
Hancock Whitney Corp.	0.01%
Cullen/Frost Bankers, Inc.	0.01%
Old Republic International Corp.	0.01%
Unknown	27.13%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	54.19%
United Kingdom	7.66%
Canada	3.2%
Norway	1.48%
Australia	0.85%
France	0.83%
Japan	0.75%
Sweden	0.58%
Switzerland	0.57%
Germany	0.55%
Denmark	0.44%
Hong Kong	0.39%
South Korea	0.29%
Ireland	0.16%
Netherlands	0.15%
Italy	0.13%
Belgium	0.13%
Luxembourg	0.11%
Finland	0.07%
New Zealand	0.05%
Singapore	0.04%
Individuals	0.04%
Spain	0.03%
Austria	0.03%
Portugal	0.03%
Czech Republic	0.03%
Liechtenstein	0.02%
South Africa	0.02%
Malaysia	0.01%
Brazil	0.01%
Saudi Arabia	0.01%
China	0.01%
Slovenia	0.01%

Based on 1000 largest holdings

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; At the end of 2025, Johnson & Johnson has 63 manufacturing facilities located in the United States (22), North America (7), Europe (22), Africa and Asia/Pacific (12). The United States accounts for 57.1% of net sales.

Employees

138,200

Sector

Pharmaceuticals

Calendar

05-26 - Ex-dividend date - 1.34 USD

More about the company